Clinical activity of the anti-CD19 bite (R) blinatumomab in patients with relapsed/refractory B-precursor acute lymphoblastic leukemia (ALL):Interim results of a phase II study

查看全文 作　　者：Topp;M;S;Goekbuget;N;Zugmaier;G